news

Monash University and oNKo-innate Announce Research Partnership
Onko-Innate, Gilead, Kite Work On NK Cancer Immunotherapies
Immunotherapy biotech scores Gilead partnership
Interest builds in next-generation cancer immunotherapies
Gilead, oNKo-innate to develop NK cells-focused cancer immunotherapies
Gilead, Kite pen natural killer pact with little-known Australian cell therapy player
Amid remdesivir craze Gilead finds time for another oncology pact — looping in all things NK cells
Announcing research collaboration with Gilead and Kite
Congratulations to our CSO for winning the 2019 Jacques Miller Medal